This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...